1299 related articles for article (PubMed ID: 26934220)
1. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
Warren TK; Jordan R; Lo MK; Ray AS; Mackman RL; Soloveva V; Siegel D; Perron M; Bannister R; Hui HC; Larson N; Strickley R; Wells J; Stuthman KS; Van Tongeren SA; Garza NL; Donnelly G; Shurtleff AC; Retterer CJ; Gharaibeh D; Zamani R; Kenny T; Eaton BP; Grimes E; Welch LS; Gomba L; Wilhelmsen CL; Nichols DK; Nuss JE; Nagle ER; Kugelman JR; Palacios G; Doerffler E; Neville S; Carra E; Clarke MO; Zhang L; Lew W; Ross B; Wang Q; Chun K; Wolfe L; Babusis D; Park Y; Stray KM; Trancheva I; Feng JY; Barauskas O; Xu Y; Wong P; Braun MR; Flint M; McMullan LK; Chen SS; Fearns R; Swaminathan S; Mayers DL; Spiropoulou CF; Lee WA; Nichol ST; Cihlar T; Bavari S
Nature; 2016 Mar; 531(7594):381-5. PubMed ID: 26934220
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir.
Tchesnokov EP; Feng JY; Porter DP; Götte M
Viruses; 2019 Apr; 11(4):. PubMed ID: 30987343
[TBL] [Abstract][Full Text] [Related]
3. Will There Be a Cure for Ebola?
Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of obeldesivir protects nonhuman primates against
Cross RW; Woolsey C; Chu VC; Babusis D; Bannister R; Vermillion MS; Geleziunas R; Barrett KT; Bunyan E; Nguyen AQ; Cihlar T; Porter DP; Prasad AN; Deer DJ; Borisevich V; Agans KN; Martinez J; Harrison MB; Dobias NS; Fenton KA; Bilello JP; Geisbert TW
Science; 2024 Mar; 383(6688):eadk6176. PubMed ID: 38484056
[TBL] [Abstract][Full Text] [Related]
5. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection.
Warren TK; Whitehouse CA; Wells J; Welch L; Heald AE; Charleston JS; Sazani P; Reid SP; Iversen PL; Bavari S
mBio; 2015 Feb; 6(1):. PubMed ID: 25670780
[TBL] [Abstract][Full Text] [Related]
6. Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.
Siegel D; Hui HC; Doerffler E; Clarke MO; Chun K; Zhang L; Neville S; Carra E; Lew W; Ross B; Wang Q; Wolfe L; Jordan R; Soloveva V; Knox J; Perry J; Perron M; Stray KM; Barauskas O; Feng JY; Xu Y; Lee G; Rheingold AL; Ray AS; Bannister R; Strickley R; Swaminathan S; Lee WA; Bavari S; Cihlar T; Lo MK; Warren TK; Mackman RL
J Med Chem; 2017 Mar; 60(5):1648-1661. PubMed ID: 28124907
[TBL] [Abstract][Full Text] [Related]
7. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses.
Lo MK; Jordan R; Arvey A; Sudhamsu J; Shrivastava-Ranjan P; Hotard AL; Flint M; McMullan LK; Siegel D; Clarke MO; Mackman RL; Hui HC; Perron M; Ray AS; Cihlar T; Nichol ST; Spiropoulou CF
Sci Rep; 2017 Mar; 7():43395. PubMed ID: 28262699
[TBL] [Abstract][Full Text] [Related]
8. Late Ebola virus relapse causing meningoencephalitis: a case report.
Jacobs M; Rodger A; Bell DJ; Bhagani S; Cropley I; Filipe A; Gifford RJ; Hopkins S; Hughes J; Jabeen F; Johannessen I; Karageorgopoulos D; Lackenby A; Lester R; Liu RS; MacConnachie A; Mahungu T; Martin D; Marshall N; Mepham S; Orton R; Palmarini M; Patel M; Perry C; Peters SE; Porter D; Ritchie D; Ritchie ND; Seaton RA; Sreenu VB; Templeton K; Warren S; Wilkie GS; Zambon M; Gopal R; Thomson EC
Lancet; 2016 Jul; 388(10043):498-503. PubMed ID: 27209148
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611
[TBL] [Abstract][Full Text] [Related]
10. Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine
Mackman RL; Hui HC; Perron M; Murakami E; Palmiotti C; Lee G; Stray K; Zhang L; Goyal B; Chun K; Byun D; Siegel D; Simonovich S; Du Pont V; Pitts J; Babusis D; Vijjapurapu A; Lu X; Kim C; Zhao X; Chan J; Ma B; Lye D; Vandersteen A; Wortman S; Barrett KT; Toteva M; Jordan R; Subramanian R; Bilello JP; Cihlar T
J Med Chem; 2021 Apr; 64(8):5001-5017. PubMed ID: 33835812
[TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Sheahan TP; Sims AC; Graham RL; Menachery VD; Gralinski LE; Case JB; Leist SR; Pyrc K; Feng JY; Trantcheva I; Bannister R; Park Y; Babusis D; Clarke MO; Mackman RL; Spahn JE; Palmiotti CA; Siegel D; Ray AS; Cihlar T; Jordan R; Denison MR; Baric RS
Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659436
[TBL] [Abstract][Full Text] [Related]
12. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
13. Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease.
Wang H; Wong G; Zhu W; He S; Zhao Y; Yan F; Rahim MN; Bi Y; Zhang Z; Cheng K; Jin H; Cao Z; Zheng X; Gai W; Bai J; Chen W; Zou Y; Gao Y; Gao GF; Yang S; Xia X; Qiu X
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541860
[TBL] [Abstract][Full Text] [Related]
14. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
Tshiani Mbaya O; Mukumbayi P; Mulangu S
Front Immunol; 2021; 12():721328. PubMed ID: 34526994
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Dong L; Garza NL; Donnelly G; Cazares LH; Nuss J; Soloveva V; Koistinen KA; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
Antiviral Res; 2018 Mar; 151():97-104. PubMed ID: 29289666
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effect of ranpirnase against Ebola virus.
Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
[TBL] [Abstract][Full Text] [Related]
18. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
Guedj J; Piorkowski G; Jacquot F; Madelain V; Nguyen THT; Rodallec A; Gunther S; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X
PLoS Med; 2018 Mar; 15(3):e1002535. PubMed ID: 29584730
[TBL] [Abstract][Full Text] [Related]
19. The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections.
Hickman MR; Saunders DL; Bigger CA; Kane CD; Iversen PL
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010220. PubMed ID: 35259154
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
